117 related articles for article (PubMed ID: 31700821)
1. The Expression Level of
Huang Y; Luo M; Huang J; Huang S; Wei L; Zhang Y; Zhang Z
Iran J Public Health; 2019 Sep; 48(9):1654-1662. PubMed ID: 31700821
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of BRCA1/2 mRNA expression for response to neoadjuvant chemotherapy in BRCA-negative breast cancers.
Xu Y; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
Cancer Sci; 2018 Jan; 109(1):166-173. PubMed ID: 29047188
[TBL] [Abstract][Full Text] [Related]
3. Response to neo-adjuvant chemotherapy in BRCA1 and BRCA2 related stage III breast cancer.
Hubert A; Mali B; Hamburger T; Rottenberg Y; Uziely B; Peretz T; Kadouri L
Fam Cancer; 2009; 8(3):173-7. PubMed ID: 19016350
[TBL] [Abstract][Full Text] [Related]
4. [Relationship of clinicopathological features and chemotherapeutic outcomes in women with BRCA1 and BRCA2 mutation-negative familial breast cancer].
Zhang J; Sun J; Ouyang T; Li JF; Wang TF; Fan ZQ; Fan T; Lin BY; Xie YT
Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):185-9. PubMed ID: 26988823
[TBL] [Abstract][Full Text] [Related]
5. Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer.
Drooger JC; Heemskerk-Gerritsen BAM; Smallenbroek N; Epskamp C; Seynaeve CM; Jager A
Breast Cancer Res Treat; 2016 Apr; 156(3):557-566. PubMed ID: 27060914
[TBL] [Abstract][Full Text] [Related]
6. Reduced canine BRCA2 expression levels in mammary gland tumors.
Yoshikawa Y; Morimatsu M; Ochiai K; Ishiguro-Oonuma T; Wada S; Orino K; Watanabe K
BMC Vet Res; 2015 Jul; 11():159. PubMed ID: 26202431
[TBL] [Abstract][Full Text] [Related]
7. Germline Mutation Status, Pathological Complete Response, and Disease-Free Survival in Triple-Negative Breast Cancer: Secondary Analysis of the GeparSixto Randomized Clinical Trial.
Hahnen E; Lederer B; Hauke J; Loibl S; Kröber S; Schneeweiss A; Denkert C; Fasching PA; Blohmer JU; Jackisch C; Paepke S; Gerber B; Kümmel S; Schem C; Neidhardt G; Huober J; Rhiem K; Costa S; Altmüller J; Hanusch C; Thiele H; Müller V; Nürnberg P; Karn T; Nekljudova V; Untch M; von Minckwitz G; Schmutzler RK
JAMA Oncol; 2017 Oct; 3(10):1378-1385. PubMed ID: 28715532
[TBL] [Abstract][Full Text] [Related]
8. Mammary tumor induction and premature ovarian failure in ApcMin mice are not enhanced by Brca2 deficiency.
Bennett LM; McAllister KA; Ward T; Malphurs J; Collins NK; Seely JC; Davis BJ; Wiseman RW
Toxicol Pathol; 2001; 29(1):117-25. PubMed ID: 11215675
[TBL] [Abstract][Full Text] [Related]
9. Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues.
Rajan JV; Marquis ST; Gardner HP; Chodosh LA
Dev Biol; 1997 Apr; 184(2):385-401. PubMed ID: 9133444
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of anthracycline/taxane-based neo-adjuvant chemotherapy on triple-negative breast cancer in BRCA1/BRCA2 mutation carriers.
Bignon L; Fricker JP; Nogues C; Mouret-Fourme E; Stoppa-Lyonnet D; Caron O; Lortholary A; Faivre L; Lasset C; Mari V; Gesta P; Gladieff L; Hamimi A; Petit T; Velten M
Breast J; 2018 May; 24(3):269-277. PubMed ID: 28929593
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of BRCA2 and RAD51 in lymph node metastases of canine mammary adenocarcinomas.
Klopfleisch R; Gruber AD
Vet Pathol; 2009 May; 46(3):416-22. PubMed ID: 19176491
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of Neoadjuvant Therapy with Platinum-Based Agents for Patients with BRCA1 and BRCA2 Germline Mutations - A Retrospective Analysis of Breast Cancer Patients Treated at MMCI Brno.
Holánek M; Bílek O; Nenutil R; Kazda T; Selingerová I; Zvaríková M; Palácová M; Krásenská M; Vyzula R; Petráková K
Klin Onkol; 2019; 32(Supplementum2):31-35. PubMed ID: 31409079
[TBL] [Abstract][Full Text] [Related]
13. Brca2 deficiency does not impair mammary epithelium development but promotes mammary adenocarcinoma formation in p53(+/-) mutant mice.
Cheung AM; Elia A; Tsao MS; Done S; Wagner KU; Hennighausen L; Hakem R; Mak TW
Cancer Res; 2004 Mar; 64(6):1959-65. PubMed ID: 15026330
[TBL] [Abstract][Full Text] [Related]
14. Mutations of BRCA2 in canine mammary tumors and their targeting potential in clinical therapy.
Thumser-Henner P; Nytko KJ; Rohrer Bley C
BMC Vet Res; 2020 Jan; 16(1):30. PubMed ID: 32005245
[TBL] [Abstract][Full Text] [Related]
15. Novel variations and loss of heterozygosity of BRCA2 identified in a dog with mammary tumors.
Yoshikawa Y; Morimatsu M; Ochiai K; Nagano M; Tomioka Y; Sasaki N; Hashizume K; Iwanaga T
Am J Vet Res; 2008 Oct; 69(10):1323-8. PubMed ID: 18828690
[TBL] [Abstract][Full Text] [Related]
16. Should BRCA2 mutation carriers avoid neoadjuvant chemotherapy?
Raphael J; Mazouni C; Caron O; Ferchiou M; Delaloge S
Med Oncol; 2014 Mar; 31(3):850. PubMed ID: 24448978
[TBL] [Abstract][Full Text] [Related]
17. Liquid biopsy can detect BRCA2 gene variants in female dogs with mammary neoplasia.
de Oliveira JR; Colombo J; Gonçalves FM; de Carvalho LAL; Costa DS; Henrique T; Novais AA; Moschetta-Pinheiro MG; Chuffa LGA; Coutinho LL; Santana ÁE; Zuccari DAPC
Vet Comp Oncol; 2022 Mar; 20(1):164-171. PubMed ID: 34328705
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity to first-line chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers.
Kriege M; Seynaeve C; Meijers-Heijboer H; Collee JM; Menke-Pluymers MB; Bartels CC; Tilanus-Linthorst MM; Blom J; Huijskens E; Jager A; van den Ouweland A; van Geel B; Hooning MJ; Brekelmans CT; Klijn JG
J Clin Oncol; 2009 Aug; 27(23):3764-71. PubMed ID: 19564533
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of taxane chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers.
Kriege M; Jager A; Hooning MJ; Huijskens E; Blom J; van Deurzen CH; Bontenbal M; Collee JM; Menke-Pluijmers MB; Martens JW; Seynaeve C
Cancer; 2012 Feb; 118(4):899-907. PubMed ID: 21761396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
